Anesiva, Inc.
|
Anesiva, Inc. (Anesiva) is a biopharmaceutical company focused on the development and commercialization of therapeutic treatments for pain management. Its portfolio of products includes Zingo powder intradermal injection system, which was approved by the United States Food and Drug Administration (FDA) in August 2007, and Adlea, which is a long-acting, site-specific, non-opioid analgesic, being developed for moderate to severe pain, and has completed multiple Phase II trials in post-surgical, musculoskeletal and neuropathic pain. In October 2007, it announced that its Phase III clinical trial in adults requested by FDA met its primary endpoint.
(Source: 10-K)
More from Zoominfo » |
Anesiva, Inc. Interview Questions.
It's always hard to know what to expect when going in for that interview -- and preparation can make all the difference. What is the interview...
What's the company culture at Anesiva, Inc.?
Every business has its own style. What is the office environment and culture like at Anesiva, Inc.?
Are people dressed in business casual, jeans...
How to get a job at Anesiva, Inc..
Do you work at Anesiva, Inc.? How did you find the job? How did you get that first interview?
Any advice for someone trying to get in?
Anesiva, Inc. News and Gossip.
What do you think - will Anesiva, Inc. grow fast? Are they expanding their staff? How does Anesiva, Inc. stack up against the competition?
Anesiva, Inc. Salaries, Bonuses and Benefits.
What are the average starting salaries, bonuses, benefits and travel requirements like at Anesiva, Inc.?
What do you like best about working at...
More Anesiva, Inc. discussions
|
|
ANSV....Anesiva Inc
O: Quote, Profile, Research, Stock Buzz) experimental pain drug Adlea met the main goal of a late-stage trial, raising hopes that the tiny biopharmaceutical company may find a partner to further develop the drug and prompting a six-fold ...
From
Stock Market Forum, Penny Stoc...
- by Aufan 1983 - 23 days ago
Anesiva, Inc. Phase 3 Trial of Adlea Meets Primary Endpoint to ...
The company's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for the management of acute pain following orthopedic surgeries. Adlea has been shown in previous clinical ...
From
Biospace.com Featured News
- 23 days ago
Anesiva, Inc. Commences Phase 2 Trial of Adlea
Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products for pain management. The company's first commercial product, Zingo(TM), ...
From
Biospace.com Featured News
- 5 months ago
More blog posts from Google Blog Search
|
|
